caseintelcaseintel

Mass Tort Data Intelligence

Real-time docket tracking, filing velocity, and litigation intelligence across 50 active mass tort dockets.

ACTIVE TORTS 50·TOTAL CASES 306,033+·NEW THIS WEEK ~951·UPCOMING TRIALS 6·Social Media10K+↑·Depo-Provera3.5K+↑↑·Hair Relaxer15.1K↑·Talc / J&J67.2K+→·AFFF / PFAS15.3K+→·Ozempic NAION73+↑↑·PowerPort3K+↑·Lyft Assault170+↑↑·
ACTIVE TORTS 50·TOTAL CASES 306,033+·NEW THIS WEEK ~951·UPCOMING TRIALS 6·Social Media10K+↑·Depo-Provera3.5K+↑↑·Hair Relaxer15.1K↑·Talc / J&J67.2K+→·AFFF / PFAS15.3K+→·Ozempic NAION73+↑↑·PowerPort3K+↑·Lyft Assault170+↑↑·
Market AlertSeptember 14, 2026

Roundup: Bayer Seeks Approval of $7.25 Billion Settlement

At a September 14, 2026 hearing, Monsanto urged a Missouri judge to approve its proposed Roundup cancer settlement. The plan would provide up to $7.25 billion over as many as 21 years for qualifying current and future claims. Final approval was not confirmed in sources reviewed September 26.

Source: Bayer: September 14 settlement hearing
Browse Archive·1 of 10
Intelligence Feed Network14 active sources
CourtListener / PACER50
Google News RSS84
FDA Drug Alerts335
FDA FAERS1,104
PubMed / NCBI67
ClinicalTrials.gov42
JPML MDL Stats28
Class Action Filings19
Market Data56
Federal Register127
CPSC Recalls15
SEC EDGAR38
DOJ / Legal Enforcement22
CDC MMWR31
Total signals:2,018
Polling every 6–12h

Plaintiff Firm Rankings — Oct 21 – Nov 3, 2026

#FirmCityActive DocketsNewLeadership Status
1Motley Rice LLCMt. Pleasant, SCSocial Media, AFFF, Talc45PSC — MDL 3047, MDL 2873
2Levin Papantonio RaffertyPensacola, FLAFFF, Hair Relaxer, PowerPort38Co-Lead — MDL 2873
3Beasley AllenMontgomery, ALParagard, Ozempic, Hair Relaxer32PSC — MDL 3094, MDL 2750
4Seeger Weiss LLPNew York, NYAcetaminophen, FreeStyle Libre, Social Media30Co-Lead — MDL 3043
5Wisner BaumLos Angeles, CAAcetaminophen, Depo-Provera, Social Media28PSC — MDL 3043, MDL 3140
6Slater Slater SchulmanNew York, NYUber, Lyft, Social Media25Lead — MDL 3084
7TorHoerman LawEdwardsville, ILHair Relaxer, Paragard, Social Media22PSC — MDL 3060
8Weitz & LuxenbergNew York, NYFreeStyle Libre, 1,4-Dioxane, Talc20PSC — MDL 2738

MDL Case Count Tracker — Oct 21 – Nov 3, 2026

50 dockets
TortMDL #TotalNew (Wk)TrendKey Development
Tech
Pre-MDL~500+~35
FAST
State AG actions accelerating. Epic Games $520M FTC precedent. MDL formation expected 2026.
Tech
304710,000+~30
ACTIVE
AG claims resolved ($18B, Aug 26). Individual-injury docket post-Daubert; JCCP 5255 two-plaintiff trial v. Meta opened Oct 28.
Talc / J&JBorderline
Consumer
273867,200+~45
FILING
CA $950M verdict vacated Mar 17. Continued high-volume filing.
Consumer
3060~15,100~25
ACTIVE
BELLWETHER SELECTION: Judge Rowland selected 3 cases Apr 1.
Chemical
287315,250+~40
FILING
Steady high-volume intake. Motley Rice, Levin Papantonio active.
Device
284623,800+~50
FILING
Continued largest filing volume.
Pharma
31403,490+~40
FAST
Expert deps completed Mar 20. Preemption motion under advisement.
Pharma
3092~8,500~5
FLAT
Bellwether discovery continues.
Pharma
30943,546+~20
ACTIVE
Entering critical Daubert/SJ phase.
Device
30813,044+~40
ACTIVE
TRIAL IMMINENT: Cook bellwether Apr 21.
Paragard IUDBorderline
Device
27503,600+~25
FILING
Beasley Allen, TorHoerman active. Mediation ongoing.
Pharma
316373+~19
FAST
Separate MDL created Dec 2025. NJ MCL active in parallel.
Pharma
3043~3,025~25
FILING
Seeger Weiss, Wisner Baum active.
Tech
3171~170~20
FAST
Rapid intake continues.
Tech
30842,075+~15
FILING
Slater Slater Schulman active.
Device
3172~400~10
FILING
Mediation ongoing. Bellwether May 26.
Pharma
318018+~5
FAST
JPML MDL motion filed. Ruling expected soon.
Consumer
Pre-MDL~325~25
FAST
Pre-MDL. Multiple firms active.
Device
Pre-MDL~215~15
FILING
Seeger Weiss, Weitz & Luxenberg active.
Chemical
E.D.N.Y30+~3
FILING
Weitz & Luxenberg, Napoli Shkolnik active.
Consumer
Pre-MDL~22~4
FILING
JPML Birmingham hearing Mar 26. Ruling imminent.
Chemical
27414,200+~15
ACTIVE
Bayer settlement ongoing. New cases still filing.
Chemical
E.D.N.C.95,000+~200
FILING
PACT Act claims. Federal government defendant.
Pharma
29242,100+~2
FLAT
Most claims dismissed. Science rulings unfavorable.
Chemical
30045,400+~35
FILING
Parkinson's disease link. Syngenta/Chevron defendants.
Consumer
Pre-MDL~500~20
FAST
Emerging ovarian cancer claims separate from J&J.
Consumer
30261,800+~12
ACTIVE
Abbott/Mead Johnson. Premature infant NEC claims.
Pharma
3043~3,025~25
FILING
Autism/ADHD link. Retailers as defendants.
Pharma
Pre-MDL~200~10
FAST
Hearing loss side effect. Horizon Therapeutics.
Device
3014750+~8
ACTIVE
Foam degradation. Cancer risk claims.
ElmironBorderline
Pharma
29731,200+~3
FLAT
Vision damage. Settlement discussions ongoing.
Device
3044900+~10
FILING
Polyethylene insert failures.
BelviqOpen
Pharma
Pre-MDL~150~8
FAST
Cancer risk. Pulled from market 2020.
Chemical
Pre-MDL~400~15
FAST
PFAS exposure. Emerging litigation.
Consumer
Pre-MDL~300~10
FILING
Heavy metals in baby food. Multiple defendants.
FluoroquinoloneBorderline
Pharma
Pre-MDL~250~2
FLAT
Cipro/Levaquin. Peripheral neuropathy.
Pharma
278912,000+~5
FLAT
Nexium/Prilosec. Kidney damage. Mostly settled.
Device
26413,800+~3
FLAT
Bard/Cook. Filter migration/fracture.
RisperdalClosed
Pharma
2767900+~2
FLAT
Gynecomastia. Most cases resolved.
Device
2885Settled0
FLAT
$6B settlement complete. Monitoring ongoing.
ValsartanClosed
Pharma
28751,400+~3
FLAT
NDMA contamination. Cancer claims.
Consumer
30384,500+~15
ACTIVE
Youth vaping. School district claims.
Other
Pre-MDL~50~3
FAST
Antitrust. PGA merger implications.
Tech
Pre-MDL~100~5
FILING
Driver-on-passenger assault claims.
Tech
Pre-MDL~75~4
FAST
Data privacy violations. CCPA claims.
Chemical
23422,500+~10
FILING
Environmental contamination. School claims.
Consumer
2738Part of Talc~20
FILING
Subset of Talc MDL.
Pharma
Pre-MDL~100~5
FAST
Autoimmune injury claims. Merck defendant.
Device
22444,000+~2
FLAT
DePuy/Stryker. Mostly resolved.
Pharma
Pre-MDL~50~3
FAST
Immune-related organ failure. Merck defendant.

Critical Dates — Next 60 Days

12 events
DateDocketEventInvestor Significance
Nov 9, 2026Camp Lejeune Litigation (E.D.N.C.)First kidney cancer Track 1 bench trial (Mousser) before Judge Boyle — sources conflict (Oct 27 vs Nov 9 vs Nov 16 for Mousser/Fancher); unconfirmedFirst Track 1 trial outcomes would set value benchmarks across roughly 95,000 pending claims.
Nov 10, 2026Social Media JCCP 5255Meta CEO Mark Zuckerberg tentatively expected to testify in the S.J./K.D.B. bellwether before Judge Kuhl (tentative per Daily Journal)Executive testimony raises verdict and settlement pressure on Meta in the first post-multistate-deal PI trial.
Nov 16, 2026Hair Relaxer MDL 3060Bellwether expert discovery closes (Judge Rowland, N.D. Ill.)Gates dispositive motions due Dec 16; first trials now projected 2027
Nov 16, 2026Camp Lejeune Litigation (E.D.N.C.)Next in-person hearing in Wilmington per late-reporting trackers (unconfirmed against a court order)Checkpoint on Track 1 trial sequencing and global settlement progress after the Oct 30 target.
Nov 17, 2026Ozempic MDL 3094Status conference before Judge Marston (E.D. Pa.)Second post-Daubert-hearing checkpoint; ruling on general causation could land before or at this conference
Nov 19, 2026Social Media JCCP 5255Instagram head Adam Mosseri tentatively scheduled to testify before Judge Kuhl (tentative)Second senior-executive witness; timing signals trial length and likely jury submission date.
Nov 19, 2026J&J Talc MDL 2738Plaintiffs' 90-day response deadline to Judge Singh's July 22 specific-causation order to show causeDetermines whether non-settling claims survive the withdrawn-expert problem; runs alongside the 95%-participation threshold on the $5.5B+ deal
Nov 20, 2026AFFF MDL 2873Proposals due for selecting Group B personal-injury bellwether cases (thyroid disease, ulcerative colitis) — Judge Gergel (D.S.C.)Only live PI milestone after the Oct 2025 kidney-cancer trial was vacated; shapes when a first PI trial can be set
Nov 30, 2026Depo-Provera MDL 3140Firm registration deadline for the Pfizer master settlement (Judge Rodgers' Aug 10 order; BrownGreer administering)Irrevocable enrollment cutoff; ~80% of eligible plaintiffs expected to qualify; payments begin Q1 2027
Dec 1, 2026Bard PowerPort MDL 3081Hicks bellwether trial begins (set Dec 1–21 under First Amended CMO 50)Third jury test in four months; outcome likely triggers global settlement talks
Dec 15, 2026Ozempic MDL 3094Status conference before Judge Marston (E.D. Pa.)Year-end checkpoint; if Daubert is decided by then, bellwether selection follows
Dec 16, 2026Hair Relaxer MDL 3060Case-specific summary-judgment and expert-admissibility motions due, Judge Rowland (proposed, unconfirmed; one tracker lists Nov 16 instead)First case-specific dispositive motions ahead of the Sept 7, 2027 first bellwether trial.

New Filings — Oct 21 – Nov 3, 2026

CaseDefendantCourtTheoryLead Firm
Rodriguez v. Meta PlatformsMeta Platforms, Inc.N.D. Cal.Product liability — algorithmic addictionMotley Rice LLC
Thompson v. Bard MedicalBard Medical / BDD. Ariz.Device failure — catheter fractureLevin Papantonio
Williams v. Pfizer Inc.Pfizer Inc.S.D.N.Y.Failure to warn — Depo-Provera meningiomaWisner Baum
Garcia v. Novo NordiskNovo Nordisk A/SE.D. Pa.GLP-1 gastroparesis / bowel obstructionBeasley Allen
Davis v. Lyft, Inc.Lyft, Inc.N.D. Cal.Negligent hiring — sexual assaultSlater Slater Schulman
Chen v. Abbott LabsAbbott LaboratoriesN.D. Ill.Device defect — FreeStyle Libre burnsSeeger Weiss LLP
Investor Intelligence

Analyst Notes & Portfolio Strategy

Priority assessments, stage analysis, and portfolio positioning across active mass tort dockets.

Analyst Notes — Investor Outlook

Social Media Youth Addiction

Elevated Priority

The NM verdict fundamentally shifts the litigation landscape. Federal bellwether on June 15 is the next major catalyst. Expect heightened settlement pressure on Meta/Google. Monitor appellate timeline closely — a sustained verdict dramatically increases portfolio exposure.

View docket details →

Talc / J&J

Bankruptcy Watch

Third prepackaged bankruptcy attempt (June 2 hearing) remains the central variable. CA verdict vacation adds complexity. Resolution of 67K+ claims hinges on bankruptcy court approval of $8.9B trust proposal.

View docket details →

Hair Relaxer

Trial Preparation

Bellwether selections signal active progression. Three cases chosen April 1 will define trial strategy. L'Oreal, Revlon exposure significant. Watch for Daubert rulings on causation experts in coming weeks.

View docket details →

Depo-Provera

Elevated Priority

Preemption ruling (expected May 5) is threshold issue. If denied, rapid case growth likely accelerates. Pfizer exposure could be substantial given long market history and meningioma causation evidence.

View docket details →

Ozempic / GLP-1

Critical Juncture

May 12 Daubert hearing is make-or-break. Favorable ruling opens massive liability exposure for Novo Nordisk and Eli Lilly. Unfavorable ruling could significantly deflate docket. High-stakes binary outcome.

View docket details →

Bard PowerPort

Trial Imminent

Cook Medical bellwether (April 21) is the first catheter port trial. Outcome will set settlement benchmarks. BD/Bard cases to follow. Device failure evidence is strong — favorable plaintiff verdict expected.

View docket details →

Opportunities by Stage

Emerging< 45
·Monsanto PCB
·Exactech Implant
·Philips CPAP
·Juul / E-Cigarettes
·Video Game Addiction
·Talcum Powder (Cosmetic)
·Firefighter Cancer
·Nitrous Oxide

Early signals. Pre-MDL formation. First-mover window.

Formation45–55
·NEC Baby Formula
·Cartiva SCI
·Paragard IUD
·Hair Relaxer
·Suboxone Tooth Decay
·Acetaminophen ASD
·Dupixent CTCL
·Ozempic NAION

Active investigation. Firms building inventory.

Active Litigation55–70
·Hernia Mesh (Bard)
·AFFF Firefighting Foam
·Social Media Addiction
·Bard PowerPort
·Camp Lejeune Water
·Paraquat
·Uber Sexual Assault
·Ozempic / GLP-1

Post-Daubert. Bellwethers and trial-by-trial.

Maturation70+
·Depo-Provera
·Talc / J&J
·Roundup / Monsanto

Settlement pressure. Global deal in motion.

Litigation Stage Tracker
12 Key Dockets
Docket Market

The Diversified Core Portfolio

8 curated mass tort positions across 5 sectors and 4 stages.

8Positions
5Sectors
4Stages
View Portfolio →
Weekly Intelligence Brief

Don't miss a ruling, verdict, or filing.

Every Monday: critical docket developments, filing velocity changes, bellwether outcomes, and portfolio signals — in one email.

2 min read·Free forever·Unsubscribe anytime
Trusted Intel Intake

Upload expert documents into the live docket board

Upload litigation reports, filings, or normalized JSON. Trusted docket facts become homepage overrides when they match a live MDL or tracked docket.

6
Recent Uploads
0
Facts
0
Events
No file selected yet.

Recent Intel Activity

Newest first
May 2026 Litigation Guide
WL · 5/13/2026, 12:56:57 AM
STORED_RAW
Facts 0Events 0
Social Media Harm Intake Criteria Feb 3 2025.pdf
Unknown publisher · 5/13/2026, 12:47:39 AM
STORED_RAW
Facts 0Events 0
Semaglutide NAION Intake Criteria Jul 29 2025.pdf
Unknown publisher · 5/13/2026, 12:47:34 AM
STORED_RAW
Facts 0Events 0
May Update
WL · 5/13/2026, 12:47:29 AM
STORED_RAW
Facts 0Events 0
Diag PDF Upload
Unknown publisher · 5/13/2026, 12:41:33 AM
STORED_RAW
Facts 0Events 0
Diagnostic Test Upload
Claude Diagnostic · 5/13/2026, 12:40:47 AM
TEXT_CAPTURED
Facts 0Events 0